JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB210543

Anti-TIM 3 antibody [EPR20767]

Be the first to review this product! Submit a review

|

(4 Publications)

Rabbit Recombinant Monoclonal TIM 3 antibody. Suitable for IP, Flow Cyt, WB and reacts with Human samples. Cited in 4 publications.

View Alternative Names

CD366, TIM3, TIMD3, HAVCR2, Hepatitis A virus cellular receptor 2, HAVcr-2, T-cell immunoglobulin and mucin domain-containing protein 3, T-cell immunoglobulin mucin receptor 3, T-cell membrane protein 3, TIMD-3, TIM-3

4 Images
Flow Cytometry - Anti-TIM 3 antibody [EPR20767] (AB210543)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-TIM 3 antibody [EPR20767] (AB210543)

Flow cytometric analysis of human peripheral blood mononuclear cells (PBMCs) labeling TIM 3 with ab210543 at 1/500 dilution (right panel) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (left panel). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Co-staining with anti-CD14 (y-axis). CD14+ PBMCs were positive for TIM 3 (PMID 22426209). Gated on total viable cells.

Immunoprecipitation - Anti-TIM 3 antibody [EPR20767] (AB210543)
  • IP

Supplier Data

Immunoprecipitation - Anti-TIM 3 antibody [EPR20767] (AB210543)

TIM 3 was immunoprecipitated from 0.35 mg of Daudi (human Burkitt's lymphoma cell line) whole cell lysate with ab210543 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab210543 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Lane 1 : Daudi whole cell lysate 10 μg (Input).
Lane 2 : ab210543 IP in Daudi whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab210543 in Daudi whole cell lysate.

Exposure time : 10 seconds.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-TIM 3 antibody [EPR20767] (ab210543)

Predicted band size: 33 kDa,42 kDa,44 kDa

Observed band size: 50 kDa

false

Western blot - Anti-TIM 3 antibody [EPR20767] (AB210543)
  • WB

Supplier Data

Western blot - Anti-TIM 3 antibody [EPR20767] (AB210543)

Blocking/Dilution buffer : 5% NFDM/TBST.

Strong signal detected in Daudi cells after 15s exposure. Please note that under our experimental conditions (overexposure >3min), a faint band at ~70kDa was detected in Jurkat T cells (previously reported as a TIM 3 negative cell line PMID : 21807895).

All lanes:

Western blot - Anti-TIM 3 antibody [EPR20767] (ab210543) at 1/1000 dilution

All lanes:

Daudi (human Burkitt's lymphoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 33 kDa

Observed band size: 50 kDa

true

Exposure time: 15s

Western blot - Anti-TIM 3 antibody [EPR20767] (AB210543)
  • WB

Supplier Data

Western blot - Anti-TIM 3 antibody [EPR20767] (AB210543)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-TIM 3 antibody [EPR20767] (ab210543) at 1/1000 dilution

All lanes:

Fc-tagged human TIM 3 recombinant protein (aa22-200) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 33 kDa

Observed band size: 75 kDa

true

Exposure time: 3s

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20767

Isotype

IgG

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

WB, IP, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TIM-3 also known as T cell immunoglobulin and mucin-domain containing-3 or HAVCR2 is a protein involved in immune regulation. It possesses an approximate mass of 35 kDa. TIM-3 is expressed on various immune cells including T cells NK cells and dendritic cells especially after activation. The expression level often changes in response to inflammatory conditions suggesting its role in modulating immune responses.
Biological function summary

TIM-3 functions as a checkpoint inhibitor impacting immune cell activity. It is not part of a larger physical complex but it modulates immune responses by interacting with its ligands such as Galectin-9 phosphatidylserine and CEACAM1. TIM-3 involvement in downregulating Th1 cell responses shows its necessary role in maintaining immune homeostasis. The protein also acts in regulating tolerance mechanisms and preventing autoimmunity.

Pathways

TIM-3 participation is seen in the immune checkpoint and T cell exhaustion pathways. TIM-3 signaling results in T cell inhibition affecting the PD-1 pathway as well. It shares a relationship with proteins like LAG-3 and PD-1 which are key to immune inhibitory signaling. These interactions depict TIM-3's role in immune tolerance during chronic infections and malignancies.

TIM-3 association with cancer and chronic infections provides insight into therapeutic implications. In cancer TIM-3 contributes to immune evasion often co-expressed with PD-1 leading to T cell exhaustion. In autoimmune diseases TIM-3 modulation may affect disease progression by influencing immune tolerance. Understanding TIM-3's role in these contexts aids in developing targeted therapies such as anti-TIM-3 antibodies to enhance immune responses in cancer while promoting tolerance in autoimmunity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Cell surface receptor implicated in modulating innate and adaptive immune responses. Generally accepted to have an inhibiting function. Reports on stimulating functions suggest that the activity may be influenced by the cellular context and/or the respective ligand (PubMed : 24825777). Regulates macrophage activation (PubMed : 11823861). Inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance (PubMed : 14556005). In CD8+ cells attenuates TCR-induced signaling, specifically by blocking NF-kappaB and NFAT promoter activities resulting in the loss of IL-2 secretion. The function may implicate its association with LCK proposed to impair phosphorylation of TCR subunits, and/or LGALS9-dependent recruitment of PTPRC to the immunological synapse (PubMed : 24337741, PubMed : 26492563). In contrast, shown to activate TCR-induced signaling in T-cells probably implicating ZAP70, LCP2, LCK and FYN (By similarity). Expressed on Treg cells can inhibit Th17 cell responses (PubMed : 24838857). Receptor for LGALS9 (PubMed : 16286920, PubMed : 24337741). Binding to LGALS9 is believed to result in suppression of T-cell responses; the resulting apoptosis of antigen-specific cells may implicate HAVCR2 phosphorylation and disruption of its association with BAG6. Binding to LGALS9 is proposed to be involved in innate immune response to intracellular pathogens. Expressed on Th1 cells interacts with LGALS9 expressed on Mycobacterium tuberculosis-infected macrophages to stimulate antibactericidal activity including IL-1 beta secretion and to restrict intracellular bacterial growth (By similarity). However, the function as receptor for LGALS9 has been challenged (PubMed : 23555261). Also reported to enhance CD8+ T-cell responses to an acute infection such as by Listeria monocytogenes (By similarity). Receptor for phosphatidylserine (PtSer); PtSer-binding is calcium-dependent. May recognize PtSer on apoptotic cells leading to their phagocytosis. Mediates the engulfment of apoptotic cells by dendritic cells. Expressed on T-cells, promotes conjugation but not engulfment of apoptotic cells. Expressed on dendritic cells (DCs) positively regulates innate immune response and in synergy with Toll-like receptors promotes secretion of TNF. In tumor-imfiltrating DCs suppresses nucleic acid-mediated innate immune repsonse by interaction with HMGB1 and interfering with nucleic acid-sensing and trafficking of nucleid acids to endosomes (By similarity). Expressed on natural killer (NK) cells acts as a coreceptor to enhance IFN-gamma production in response to LGALS9 (PubMed : 22323453). In contrast, shown to suppress NK cell-mediated cytotoxicity (PubMed : 22383801). Negatively regulates NK cell function in LPS-induced endotoxic shock (By similarity).
See full target information HAVCR2

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

PloS one 20:e0325986 PubMed40526593

2025

Epac1 increases myosin regulatory light-chain phosphorylation, energetic cost of contraction, and susceptibility to heart failure.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshiki Ohnuki,Kenji Suita,Misao Ishikawa,Yasumasa Mototani,Megumi Nariyama,Aiko Ito,Ichiro Matsuo,Yoshio Hayakawa,Akinaka Morii,Takao Mitsubayashi,Yasutake Saeki,Yoshihiro Ishikawa,Satoshi Okumura

CytoJournal 22:41 PubMed40469710

2025

Matrix gla protein mediates CD8 T-cell exhaustion to facilitate immune evasion in intrahepatic cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohan Cao,Shiqian Lang,Yuchi Xie,Kai Zheng,Jun Liu

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 33:421-426 PubMed37190715

2023

Tim-3, PD-1, CD244 and Foxp3 Positive T Cells' Relation to the Prognosis of Dermatomyositis and Polymyositis Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Jin Ye,Qing Liu,Qingqing Fu,Bin Li,Jinchang Huang,Guoyong Zeng

Heliyon 9:e12688 PubMed36685461

2023

PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Wang,Zhiheng Lai,Yanyang Pang,Qinghui Sun,Wenli Yang,Wu Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com